cerrar
Tagged with Investment

Interview: Onder Isinay – General Manager, Biocodex Turkey
Biocodex’s new general manager gives an overview of the affiliates ‘new deal’ program, and how the company has adjusted its approach to better…

Interview: Burak Erman & Hakan Orer – Professors, Drug…
Professor Burak Erman, the leader of the Drug Research Center at Koç University, and his colleague Hakan Orer, discuss the early activities of the…

Peru: The Long Trek To Universal Healthcare Coverage
In modern terms, Peru’s healthcare system was largely underdeveloped for many years; but the economic fortune that Peru has experienced in more…

Korea: Can High R&D Spending Lead To Commercial Success?
Local flagship company Boryung has found success with its newly developed angiotension receptor blocker (ARB) Kanarb. Nine molecules currently exist…

Seoul Is Now The Most Competitive City In The World For Clinical…
The growth of clinical trials in Korea has been remarkable in recent years. The number of clinical trials performed by multinationals has shot up from…

How can Korea’s chaebols influence global biotech and pharma…
Korea’s economy has been dominated for decades by chaebols, large family-owned business conglomerates like Samsung, Hyundai, and LG, known for their…

Interview: Jung Hyun Ho – Founder & CEO, Medytox – Korea
Medytox is the most valuable pharmaceutical business in Korea, with a highly successful botulinum toxin product on the market, and can only grow…

Interview: Rovshan Tagiyev – Founder and Chairman, World…
The founder and chairman of the rapidly expanding World Medicine group of companies discusses his firm’s international expansion strategy, how he…

Interview: Uğur Bingöl – Managing Director, Ibrahim Etem…
Menarini’s Turkish subsidiary, Ibrahim Etem Menarini, has adapted to the current pharmaceutical market and is positioned to grow in several segments…

Interview: Elif Aral – Country Manager, Pfizer –…
Pfizer Turkey has taken a strong supporting role in Turkey’s current strategic development plan by localizing the production of their Prix Galien…

Korean Pharma Companies Invest More In R&D and New Drug…
“When I left Janssen, I never imagined joining a Korean company,” recalls Choi Tae-Hung, sipping a freshly brewed yujacha tea in his office on a…

Driss Chaoui – Director General, Afric-Phar – Morocco
The director general of Afric-Phar explains why it is difficult for the local players to compete with multinationals, how the Moroccan market is being…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here